NCT04897321 2026-04-15B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)St. Jude Children's Research HospitalPhase 1 Recruiting48 enrolled
NCT04901702 2026-04-13Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing SarcomaSt. Jude Children's Research HospitalPhase 1/2 Recruiting90 enrolled
NCT04715191 2026-04-06Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid TumorsBaylor College of MedicinePhase 1 Recruiting24 enrolled
NCT04851119 2026-02-24Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsChildren's Oncology GroupPhase 1/2 Recruiting147 enrolled
NCT06198296 2025-11-03Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T CellsBaylor College of MedicinePhase 1 Recruiting21 enrolled